Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antiretroviral therapy (9) 9
humans (9) 9
medicine (9) 9
female (8) 8
hiv (8) 8
human immunodeficiency virus (8) 8
index medicus (8) 8
male (8) 8
adult (7) 7
aids (7) 7
antiretroviral agents (7) 7
antiretroviral drugs (7) 7
human immunodeficiency virus--hiv (7) 7
infectious diseases (7) 7
middle aged (7) 7
mortality (7) 7
multidisciplinary sciences (7) 7
research article (7) 7
science (7) 7
acquired immune deficiency syndrome (6) 6
acquired immune deficiency syndrome--aids (6) 6
epidemiology (6) 6
highly active antiretroviral therapy (6) 6
hiv infection (6) 6
hiv infections - drug therapy (6) 6
medical research (6) 6
morbidity (6) 6
anti-hiv agents - therapeutic use (5) 5
c-reactive protein (5) 5
clinical trials (5) 5
health aspects (5) 5
interleukin (5) 5
interleukin 6 (5) 5
medicine, experimental (5) 5
risk (5) 5
viral diseases (5) 5
antiviral agents (4) 4
biomarkers (4) 4
biomarkers - blood (4) 4
clinical research design (4) 4
health risks (4) 4
hepatitis (4) 4
hiv patients (4) 4
infections (4) 4
inflammation (4) 4
interleukin-6 - blood (4) 4
interleukins (4) 4
risk factors (4) 4
therapy (4) 4
adults (3) 3
association (3) 3
biology (3) 3
cardiovascular disease (3) 3
cardiovascular diseases (3) 3
coagulation (3) 3
coronary-heart-disease (3) 3
death (3) 3
drug therapy (3) 3
gastroenterology and hepatology (3) 3
glomerular-filtration-rate (3) 3
hiv infections - blood (3) 3
hiv infections - complications (3) 3
hiv infections - mortality (3) 3
interleukin-6 (3) 3
kidney diseases (3) 3
liver (3) 3
liver diseases (3) 3
rna (3) 3
610 medicine & health (2) 2
age factors (2) 2
analysis (2) 2
antiretroviral therapy, highly active (2) 2
biochemistry (2) 2
biomarker epidemiology (2) 2
c-reactive protein - metabolism (2) 2
cancer (2) 2
care and treatment (2) 2
case-control studies (2) 2
cause of death (2) 2
cd4 antigen (2) 2
cd4 lymphocyte count (2) 2
clinic for infectious diseases (2) 2
confidence intervals (2) 2
diabetes (2) 2
disease (2) 2
drugs (2) 2
end-stage renal disease (2) 2
exposure (2) 2
fibrin fibrinogen degradation products - metabolism (2) 2
follow-up studies (2) 2
genitourinary infections (2) 2
hepatitis b (2) 2
hepatitis b virus (2) 2
hiv epidemiology (2) 2
hiv seropositivity - drug therapy (2) 2
human-immunodeficiency-virus (2) 2
hyaluronic acid (2) 2
individuals (2) 2
life expectancy (2) 2
logistic models (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Inflammation, coagulation and cardiovascular disease in HIV-infected individuals
by Duprez, Daniel A and Duprez, Daniel A and Neuhaus, Jacqueline and Neuhaus, Jacqueline and Kuller, Lewis H and Kuller, Lewis H and Tracy, Russell and Tracy, Russell and Belloso, Waldo and Belloso, Waldo and De Wit, Stephane and De Wit, Stephane and Drummond, Fraser and Drummond, Fraser and Lane, H Clifford and Lane, H. Clifford and Ledergerber, Bruno and Ledergerber, Bruno and Lundgren, Jens and Lundgren, Jens and Nixon, Daniel and Nixon, Daniel and Paton, Nicholas I and Paton, Nicholas I and Prineas, Ronald J and Prineas, Ronald J and Neaton, James D and Neaton, James D and INSIGHT SMART Study Group, SMART Study Group and INSIGHT SMART Study Grp and INSIGHT SMART Study Group and James D. Neaton1 for the INSIGHT SMART Study Group
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 9, p. e44454
Background: The SMART study was a trial of intermittent use of antiretroviral therapy (ART) (drug conservation [DC]) versus continuous use of ART (viral... 
BIOMARKERS | EVENTS | THROMBOSIS | MULTIDISCIPLINARY SCIENCES | RISK | ANTIRETROVIRAL THERAPY | DEATH | CORONARY-HEART-DISEASE | OPPORTUNISTIC DISEASE | INTERLEUKIN-6 | D-DIMER | Inflammation - complications | Cardiovascular Diseases - complications | Humans | HIV Infections - complications | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Blood Coagulation Disorders - complications | Medical research | Antiviral agents | Usage | C-reactive protein | Mortality | HIV patients | HIV (Viruses) | Risk factors | Highly active antiretroviral therapy | Interleukins | Analysis | Medicine, Experimental | Cardiovascular diseases | Health aspects | HIV infection | Toxicity | Interleukin | Health risks | Cardiovascular disease | Regression analysis | Risk analysis | Medical diagnosis | Morbidity | Antiretroviral therapy | Interleukin 6 | Regression models | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Predictions | Biomarkers | Sampling methods | Health risk assessment | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study
by Bjerk, Sonja M and Baker, Jason V and Emery, Sean and Neuhaus, Jacqueline and Angus, Brian and Gordin, Fred M and Pett, Sarah L and Stephan, Christoph and Kunisaki, Ken M and Insight Smart Study Grp and INSIGHT SMART Study Group and for the INSIGHT SMART Study Group
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e56249
Background: Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection.... 
C-REACTIVE PROTEIN | COMMUNITY-ACQUIRED PNEUMONIA | STATIN THERAPY | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | DISEASE | ALPHA | SERUM | COHORT | HUMAN-IMMUNODEFICIENCY-VIRUS | HOSPITALIZATION | Fibrin Fibrinogen Degradation Products | HIV Infections - blood | Pneumonia, Bacterial - blood | C-Reactive Protein | Humans | Middle Aged | Pneumonia, Bacterial - etiology | Risk Factors | Pulmonary Surfactant-Associated Protein D - blood | Male | Pneumonia, Bacterial - virology | Biomarkers - blood | Pneumonia, Bacterial - diagnosis | Case-Control Studies | Uteroglobin - blood | Lung - virology | Interleukin-6 - blood | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Medical research | Antiviral agents | Care and treatment | Pneumonia | C-reactive protein | AIDS treatment | Bacterial pneumonia | Mortality | HIV patients | HIV (Viruses) | Risk factors | Infection control | Highly active antiretroviral therapy | Control | Surface active agents | Interleukins | Medicine, Experimental | Biological markers | Health aspects | HIV infection | Cases | Therapy | Interleukin | Critical care | Risk | Systematic review | Infections | Family medical history | Interleukin 6 | Proteins | Hepatitis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Bacteria | Tumor necrosis factor-TNF | Chronic obstructive pulmonary disease | Hepatitis B virus | Drug therapy | Antiretroviral drugs | Statistical analysis | Diabetes mellitus | Health risks | Protein D | Inflammation | Gene expression | Patients | Antiretroviral therapy | Morbidity | CD4 antigen | Infectious diseases | Surfactant protein D | Biomarkers | Hepatitis B | Smoking | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
by Geretti, Anna Maria and Fox, Zoe and Johnson, Jeffrey A and Booth, Clare and Lipscomb, Jonathan and Stuyver, Lieven J and Tachedjian, Gilda and Baxter, John and Touloumi, Giota and Lehmann, Clara and Owen, Andrew and Phillips, Andrew and INSIGHT Strategies Management Anti and INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group and for the INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e69266
Background: Non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant mutants have been shown to emerge after interruption of suppressive NNRTI-based... 
INFECTED INDIVIDUALS | HIV | VARIANTS | MULTIDISCIPLINARY SCIENCES | EFAVIRENZ | REGIMEN | NEVIRAPINE | ASSOCIATION | DRUG-RESISTANCE MUTATIONS | INTERRUPTION | PLASMA PHARMACOKINETICS | Anti-Retroviral Agents - therapeutic use | Reverse Transcriptase Inhibitors - blood | Humans | Middle Aged | Logistic Models | Male | Chromatography, High Pressure Liquid | HIV-1 - genetics | Nevirapine - blood | Drug Resistance, Viral - genetics | DNA Mutational Analysis | Adult | Benzoxazines - blood | Female | HIV Infections - drug therapy | High-Throughput Nucleotide Sequencing | Reverse Transcriptase Inhibitors - therapeutic use | Odds Ratio | Highly active antiretroviral therapy | Antiviral agents | Medical research | Analysis | Nucleosides | Medicine, Experimental | DNA polymerases | Biological products industry | Nucleotide sequencing | High performance liquid chromatography | DNA sequencing | Drugs | Therapy | RNA-directed DNA polymerase | Nevirapine | Viremia | Population studies | Drug resistance | Efavirenz | Confidence intervals | Restarting | Rams | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Antiretroviral drugs | Interruption | Liquid chromatography | High-performance liquid chromatography | Patients | Antiretroviral therapy | Mutants | Inhibitors | Protease inhibitors | Mutation | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Factors associated with D-dimer levels in HIV-infected individuals
by Borges, Álvaro H and O'Connor, Jemma L and Phillips, Andrew N and Baker, Jason V and Vjecha, Michael J and Losso, Marcelo H and Klinker, Hartwig and Lopardo, Gustavo and Williams, Ian and Lundgren, Jens D and SILCAAT Sci Comm and INSIGHT SMART Study Grp and ESPRIT Study Grp and INSIGHT SMART Study Group and ESPRIT Study Group and SILCAAT Scientific Committee and for the INSIGHT SMART and ESPRIT Study Groups and the SILCAAT Scientific Committee
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e90978
Background: Higher plasma D-dimer levels are strong predictors of mortality in HIV+ individuals. The factors associated with D-dimer levels during HIV... 
ALL-CAUSE MORTALITY | ELDERLY PERSONS | BIOMARKERS | FIBRIN D-DIMER | MULTIDISCIPLINARY SCIENCES | DISEASE | ADULTS | COAGULATION | ANTIRETROVIRAL THERAPY | PLASMA D-DIMER | INTERLEUKIN-6 | HIV Infections - blood | Cross-Sectional Studies | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Middle Aged | Hepatitis - blood | Linear Models | Male | CD4 Lymphocyte Count | Biomarkers - blood | Coinfection - virology | Viral Load | Randomized Controlled Trials as Topic | Inflammation - metabolism | C-Reactive Protein - metabolism | Interleukin-6 - blood | Sex Factors | Adult | Female | HIV Infections - mortality | Medical research | Antiviral agents | C-reactive protein | RNA | Mortality | HIV patients | HIV (Viruses) | Diseases | Highly active antiretroviral therapy | Hepatitis | Body mass index | Interleukins | Medicine, Experimental | Diabetes | Hyaluronic acid | HIV infection | Antiretroviral drugs | Infectious diseases | Cytokines | Laboratories | Research & development--R&D | Human immunodeficiency virus--HIV | Biomarkers | Infections | Inflammation | Drug therapy | Morbidity | HIV infections | Fibrinòlisi | Plasma sanguini | HIV-positive persons | Infeccions per VIH | Persones seropositives | Fibrinolysis | Blood plasma | Research & development | R&D | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Inflammatory and coagulation biomarkers and mortality in patients with HIV infection
by Kuller, Lewis H and Tracy, Russell and Belloso, Waldo and De Wit, Stephane and Drummond, Fraser and Lane, H. Clifford and Ledergerber, Bruno and Lundgren, Jens and Neuhaus, Jacqueline and Nixon, Daniel and Paton, Nicholas I and Neaton, James D and INSIGHT SMART Study Grp and INSIGHT SMART Study Group and for the INSIGHT SMART Study Group
PLoS Medicine, ISSN 1549-1277, 10/2008, Volume 5, Issue 10, pp. 1496 - 1508
Background In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent,... 
C-REACTIVE PROTEIN | CARDIOVASCULAR HEALTH | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MYOCARDIAL-INFARCTION | IMMUNE ACTIVATION | LOGISTIC-REGRESSION ANALYSIS | ANTIRETROVIRAL THERAPY | CORONARY-HEART-DISEASE | ENDOTHELIAL FUNCTION | ACTIVATION MARKERS | HIV Infections - blood | Follow-Up Studies | Fibrin Fibrinogen Degradation Products - analysis | Humans | Logistic Models | Male | Survival Rate | Treatment Outcome | Biomarkers - blood | Case-Control Studies | Cause of Death | Inflammation - blood | Serum Amyloid P-Component - analysis | Randomized Controlled Trials as Topic | Multicenter Studies as Topic | Interleukin-6 - blood | Blood Coagulation | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | C-Reactive Protein - analysis | Odds Ratio | Serum Amyloid A Protein - analysis | Assaigs clínics | Antiretrovirals | Sida | Antiretroviral agents | AIDS (Disease) | Clinical trials | Marcadors bioquímics | Biochemical markers | Public Health and Epidemiology | Immunology and allergy | Chronic Disease Management | Infectious Diseases | AIDS | Epidemiology | HIV Infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy
by Miller, Christopher J and Baker, Jason V and Bormann, Alison M and Erlandson, Kristine M and Hullsiek, Katherine Huppler and Justice, Amy C and Neuhaus, Jacqueline and Paredes, Roger and Petoumenos, Kathy and Wentworth, Deborah and Winston, Alan and Wolfson, Julian and Neaton, James D and INSIGHT SMART Study Grp and ESPRIT Study Grp and INSIGHT SMART Study Group and ESPRIT Study Group and for the INSIGHT SMART and ESPRIT Study Groups
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e95061
Background: Non-AIDS conditions such as cardiovascular disease and non-AIDS defining cancers dominate causes of morbidity and mortality among persons with HIV... 
AIDS EVENTS | POPULATION | HEART-DISEASE | ERA | MULTIDISCIPLINARY SCIENCES | PREVENTION | RISK | DEATH | HEALTH | HUMAN-IMMUNODEFICIENCY-VIRUS | CANCER | Age Factors | Follow-Up Studies | HIV Infections - epidemiology | Humans | Middle Aged | Mortality | Risk Factors | Male | Treatment Outcome | Cause of Death | Morbidity | Antiretroviral Therapy, Highly Active | Young Adult | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Aged | Highly active antiretroviral therapy | United States | Patient outcomes | Research | Drug therapy | Health aspects | HIV infection | End-stage renal disease | Therapy | Liver | Interleukin | Medical records | Cardiovascular disease | Medical diagnosis | Risk factors | Interleukin 6 | Liver cancer | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Chronology | Age | Antiretroviral drugs | Liver diseases | Health risks | Risk analysis | Ribonucleic acid--RNA | Age factors | Estimates | Antiretroviral therapy | CD4 antigen | Kidney diseases | Cardiovascular diseases | Cancer | Smoking | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights